Ignite Creation Date:
2024-05-06 @ 2:45 AM
Last Modification Date:
2024-10-26 @ 11:23 AM
Study NCT ID:
NCT02128906
Status:
RECRUITING
Last Update Posted:
2024-03-08
First Post:
2014-04-29
Brief Title:
Radiotherapy With Cisplatin vs Docetaxel-cetuximab in HNSCC ERCC1 Biomarker Enrichment and Interaction Design
Sponsor:
Christopher Wilke
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
HCC 13-056
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Christopher Wilke
Lead Sponsor Class:
OTHER
Responsible Party:
Christopher Wilke
Responsible Party Title:
Radiation Oncologist
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None